Cryomass Technologies Inc
Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc.… Read more
Cryomass Technologies Inc (CRYM) - Total Assets
Latest total assets as of September 2024: $1.13 Million USD
Based on the latest financial reports, Cryomass Technologies Inc (CRYM) holds total assets worth $1.13 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cryomass Technologies Inc - Total Assets Trend (2017–2023)
This chart illustrates how Cryomass Technologies Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cryomass Technologies Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Cryomass Technologies Inc's total assets of $1.13 Million consist of 15.7% current assets and 84.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.1% |
| Accounts Receivable | $8.55K | 0.9% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $96.91K | 10.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2023)
This chart illustrates how Cryomass Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cryomass Technologies Inc's current assets represent 15.7% of total assets in 2023, a decrease from 100.0% in 2017.
- Cash Position: Cash and equivalents constituted 5.1% of total assets in 2023, down from 100.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 10.0% of total assets.
Cryomass Technologies Inc Competitors by Total Assets
Key competitors of Cryomass Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Cryomass Technologies Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Cryomass Technologies Inc generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Cryomass Technologies Inc is currently not profitable relative to its asset base.
Cryomass Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.04 | 0.11 | 4.05 |
| Quick Ratio | 0.04 | 0.11 | 4.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.95 Million | $ -1.76 Million | $ 10.09 Million |
Cryomass Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Cryomass Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.83 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -87.6% |
| Total Assets | $972.51K |
| Market Capitalization | $47.43K USD |
Valuation Analysis
Below Book Valuation: The market values Cryomass Technologies Inc's assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Cryomass Technologies Inc's assets decreased by 87.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cryomass Technologies Inc (2017–2023)
The table below shows the annual total assets of Cryomass Technologies Inc from 2017 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $972.51K | -87.63% |
| 2022-12-31 | $7.86 Million | -49.54% |
| 2021-12-31 | $15.58 Million | +99.84% |
| 2020-12-31 | $7.80 Million | -51.47% |
| 2019-12-31 | $16.07 Million | +2184.10% |
| 2018-12-31 | $703.56K | +657433.64% |
| 2017-12-31 | $107.00 | -- |